4.6 Article

New functions for non-collagenous domains of human collagen type IV -: Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 275, 期 11, 页码 8051-8061

出版社

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.275.11.8051

关键词

-

资金

  1. NCI NIH HHS [R29 CA74132-01] Funding Source: Medline
  2. NIDDK NIH HHS [DK18381] Funding Source: Medline

向作者/读者索取更多资源

Collagen type IV is a major component of the basal lamina of blood vessels. Six genetically distinct collagen type IV chains have been identified and are distributed in a tissue-specific manner. Here we define a novel function for soluble non-collagenous (NC1) domains of the alpha 2(TV), alpha 3(IV), and alpha 6(IV) chains of human collagen type IV in the regulation of angiogenesis and tumor growth. These NC1 domains were shown to regulate endothelial cell adhesion and migration by distinct alpha(v) and beta(1) integrin-dependent mechanisms. Systemic administration of recombinant alpha 2(IV), alpha 3(IV), and alpha 6(IV) NC1 domains potently inhibit angiogenesis and tumor growth, whereas alpha 1(TV), alpha 4(TV), and alpha 5(IV) showed little if any effect. These findings suggest that specific NC1 domains of collagen type IV may represent an important new class of angiogenesis inhibitors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据